Focusing on the facts
of COPD

Click on these common
“myth-conceptions” about COPD and
see the real facts behind them

“The majority of patients with COPD use their inhalers correctly.”

myth

See the facts

“Long-acting maintenance therapy is generally unnecessary for patients with COPD who are already on short-acting therapy.”

myth

See the facts

“Nebulized maintenance therapy should only be reserved for patients with very severe COPD.”

myth

See the facts

“Comorbidities never play a significant role in patients’ ability to use their inhaler correctly.”

myth

See the facts

“Treatment delivery device is not an important factor when choosing therapy for a patient at hospital discharge.”

myth

See the facts

“When patients’ symptoms aren’t adequately controlled on their current COPD therapy, it’s always best to add an additional therapy to achieve control.”

myth

See the facts

“Inhalation technique errors do not contribute to hospitalizations.”

myth

See the facts

This website is paid for and content developed by Mylan Specialty L.P., a Viatris Company, and Theravance Biopharma US, Inc.

VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris Company.

THERAVANCE BIOPHARMA^®, THERAVANCE^®, and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).

The Myth-Understood logo is a trademark of Mylan Specialty L.P., a Viatris Company.

Focusing on the facts of COPD

myth

myth

myth

myth

myth

myth

myth

You are about to leave www.COPDfactcheck.com

This site is designed for healthcare professionals only.

Focusing on the facts
of COPD